FDA approves new psoriasis drug - FDA Press Releases

The U.S. Food and Drug Administration today approved Siliq (brodalumab) to treat adults with moderate-to-severe plaque psoriasis. Siliq is administered as an injection.

from Food and Drug Administration--Press Releases http://ift.tt/2kLm3Kd
via IFTTT